|
|
|
|
|
|
|
|
Your First and Only Chance to Hear the FDA & CMS Address
Payers and Pharma Under One Roof
|
|
|
|
Hear the challenges and opportunities on key issues in order to succeed in a patient-centric environment. Plus:
- Get face-to-face access to the top regulatory thought leaders and policy makers from FDA and CMS
- Hear about critical trends and changes so you can create successful strategies for dealing with FDA and CMS
- Walk
away with practical, real life lessons from some of the most
experienced payers and healthcare executives on how they are dealing
with the changes
- Benchmark your operational, regulatory and strategy against all the major health plans
|
|
|
Meet Regulators from FDA and CMS:
- Janet Woodcock, MD, Director, Center for Drug Evaluation and Research, FDA
- John K. Jenkins, MD, Director of the Office of New Drugs, Center for Drug Evaluation and Research, FDA
- Tamara Syrek Jensen, JD, Deputy Director, Coverage and Analysis Group (CAG), CMS
- Niall Brennan, Acting Director, Offices of Enterprise Management (OEM), CMS
|
|
|
|
|
|
|
|
|
|
Collaborate with C-Level Healthcare Leaders:
- Dr. Trent T. Haywood, MD, JD, Chief Medical Officer & SVP, Office of Clinical Affairs, Blue Cross and Blue Shield Assc.
- Dr. Claire Levesque, Chief Medical Officer for Commercial Products, Tufts Health Plan
- Dr. Richard Migliori, MD, Executive VP, Medical Affairs, Chief Medical Officer, UnitedHealth Group
- David Polakoff , MD, M.Sc, Chief Medical Officer & Associate Dean,
Commonwealth Medicine Director, Center for Health Policy and Research,
University of Massachusetts Medical School
- William Winkenwerder, Jr., Former CEO, Highmark, Inc.
- Kevin Volpp, MD, PhD, Founding Director, Center for Health Incentives and Behavioral Economics, Leonard Davis Institute
|
|
|
|
Please use code: XP1917MCOL.
*off standard rates
|
|
|
|
|
|
|
|
|
|
